ZIMHI Trademark

Trademark Overview

On Tuesday, January 29, 2019, a trademark application was filed for ZIMHI with the United States Patent and Trademark Office. The USPTO has given the ZIMHI trademark a serial number of 88281598. The federal status of this trademark filing is REGISTERED as of Tuesday, September 6, 2022. This trademark is owned by Adamis Pharmaceuticals Corporation. The ZIMHI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in treatment of narcotic overdose
zimhi

General Information

Serial Number88281598
Word MarkZIMHI
Filing DateTuesday, January 29, 2019
Status700 - REGISTERED
Status DateTuesday, September 6, 2022
Registration Number6839743
Registration DateTuesday, September 6, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 21, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in treatment of narcotic overdose

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 21, 2019
Primary Code005
First Use Anywhere DateThursday, March 31, 2022
First Use In Commerce DateThursday, March 31, 2022

Trademark Owner History

Party NameZMI PHARMA INC.
Party Type32 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92103
Party NameDMK PHARMACEUTICALS CORPORATION
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSAN DIEGO, CA 92130
Party NameAdamis Pharmaceuticals Corporation
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameAdamis Pharmaceuticals Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130
Party NameAdamis Pharmaceuticals Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92130

Trademark Events

Event DateEvent Description
Wednesday, April 10, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 1, 2019NEW APPLICATION ENTERED
Thursday, February 21, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 10, 2019ASSIGNED TO EXAMINER
Wednesday, May 1, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 21, 2019PUBLISHED FOR OPPOSITION
Tuesday, May 21, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, January 3, 2020SOU TEAS EXTENSION RECEIVED
Friday, January 3, 2020SOU EXTENSION 1 FILED
Friday, January 3, 2020SOU EXTENSION 1 GRANTED
Tuesday, January 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 1, 2020ASSIGNED TO EXAMINER
Wednesday, July 15, 2020SOU EXTENSION 2 FILED
Wednesday, July 15, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, July 15, 2020SOU EXTENSION 2 GRANTED
Friday, July 16, 2021SOU EXTENSION 4 GRANTED
Friday, July 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 7, 2021SOU TEAS EXTENSION RECEIVED
Thursday, January 7, 2021SOU EXTENSION 3 FILED
Thursday, January 7, 2021SOU EXTENSION 3 GRANTED
Saturday, January 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 16, 2021SOU TEAS EXTENSION RECEIVED
Friday, July 16, 2021SOU EXTENSION 4 FILED
Tuesday, July 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 19, 2022STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 18, 2022ASSIGNED TO EXAMINER
Tuesday, January 18, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, January 18, 2022SOU EXTENSION 5 FILED
Thursday, January 27, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, January 27, 2022SOU EXTENSION 5 GRANTED
Friday, January 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 15, 2022TEAS STATEMENT OF USE RECEIVED
Friday, July 15, 2022USE AMENDMENT FILED
Wednesday, August 3, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 4, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, July 26, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, September 6, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, September 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Thursday, May 16, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Related Keywords

zimhi overdose narcotic treatment preparations pharmaceutical